Effectiveness & Safety of RF Microneedling and PRP in Treating Pigmentary Disorders
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Robyn Siperstein, a dermatologist in Boca Raton and Boynton Beach, FL. Watch as Dr. Siperstein explains how modalities such as microneedling can both increase and decrease pigment. Listen as she shares tips on getting the desired pigmentary effect. Hear about her pilot studies on combination therapies t …
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Robyn Siperstein, a dermatologist in Boca Raton and Boynton Beach, FL. Watch as Dr. Siperstein explains how modalities such as microneedling can both increase and decrease pigment. Listen as she shares tips on getting the desired pigmentary effect. Hear about her pilot studies on combination therapies t … 
As a dermatologist, you may roll your eyes at one of the latest TikTok trends. The co-founder of an online wellness community recently shared a recipe for a “Botox that you can make at home,” according to In the Know, a Yahoo! News outlet. Her hack is a DIY mask made of flaxseed and water. In the Know shared the posts with a dermatologist who pointed out the false claims made in the TikTok vid … 
Welcome to the December 2023 issue of the Journal of Drugs in Dermatology (JDD), where cutting-edge research and advancements in the field of dermatology take center stage. This issue brings together a diverse array of original articles, case reports, brief communications, and letters to the editor and delves into the latest developments, therapeutic breakthroughs, and cl … 
An increased level of which of the following proteins is most implicated in the pathogenesis of pruritus in the patient’s condition?
A. Defensin
B. Histamine
C. Interleukin-2
D. Interleukin-31
E. Transforming growth factor-beta
To find out the correct answer and read the explanation, click here.
Brought to you by … 
JDD authors Mihir Shah MD, Jenna Wald MD, and C. William Hanke MD MPH present a case of a patient with eruptive squamous cell carcinomas following treatment with Fludarabine to highlight not only the risk of cSCC in CLL patients and the increased risk for atypical cutaneous malignancies after treatment with systemic therapies such as fludarabine, but also to discuss treatment options for this …